• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Medicines and Healthcare Regulatory Agency (MHRA) - Articles and news items

bladder cancer

Immunotherapy treatment fast-tracked under UK’s access to medicines scheme

Industry news / 2 February 2017 / Niamh Marriott, Digital Editor

From today, UK patients with an incurable form of bladder cancer can access the new immunotherapy, atezolizumab, following a positive Scientific Opinion…

UK regulatory support for Vtesse’s Niemann-Pick drug for children

Industry news / 4 November 2016 / Niamh Louise Marriott, Digital Content Producer

The MHRA has granted a Promising Innovative Medicine designation for VTS-270, Vtesse’s investigational drug for children with Niemann-Pick Type C1 disease…

Ipsen’s kidney cancer drug receives positive CHMP and ‘Promising Innovative Medicine’ status

Industry news / 25 July 2016 / Niamh Louise Marriott, Digital Content Producer

Ipsen announced that CHMP & EMA have provided a positive opinion for Cabometyx for the treatment of advanced renal cell carcinoma (RCC) in adults…

 

Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +